{
    "clinical_study": {
        "@rank": "112632", 
        "arm_group": [
            {
                "arm_group_label": "Concordant"
            }, 
            {
                "arm_group_label": "Discordant"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate Cardiac Resynchronization Therapy(CRT) response in\n      subjects with concordant versus discordant left ventricular (LV) lead position as compared\n      to the site of latest mechanical activation."
        }, 
        "brief_title": "Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide", 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Be scheduled to undergo implant of a Cardiac Resynchronization Therapy (CRT) system\n             with approved standard indication per accepted guidelines as a new implant or an\n             upgrade from an existing Implantable Cardioverter Defibrillator (ICD) or pacemaker\n             with no prior left ventricular lead placement\n\n          -  Be in sinus rhythm at the time of enrollment\n\n          -  Have the ability to provide informed consent for study participation and be willing\n             and able to comply with the Clinical Investigational Plan described evaluations\n\n        Exclusion Criteria:\n\n          -  Have persistent or permanent atrial fibrillation\n\n          -  Be in New York Heart Association (NYHA) IV functional class\n\n          -  Have prior left ventricular (LV) lead implant\n\n          -  Be pacemaker-dependent\n\n          -  Have a recent myocardial infarction within 40 days prior to enrollment\n\n          -  Have undergone cardiac bypass surgery or coronary revascularization procedure within\n             3 months prior to enrollment or be scheduled for such procedures in the following 7\n             months\n\n          -  Have had a recent Cerebrovascular accident (CVA) or transient ischemic attack (TIA)\n             within 3 months prior to enrollment\n\n          -  Have had intravenous inotropic support in the last 30 days\n\n          -  Exhibit Cheyne-Stokes respiration\n\n          -  Be less than 18 years of age\n\n          -  Be pregnant or planning to become pregnant during the duration of the investigation\n\n          -  Be currently participating in any other clinical investigation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Heart failure patients indicated for a Cardiac Resynchronization Therapy (CRT) device"
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01917266", 
            "org_study_id": "690"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 20, 2014", 
        "location": {
            "contact": {
                "email": "hindg@medizin.uni-leipzig.de", 
                "last_name": "Gerhard Hindricks, MD", 
                "phone": "+49 (341) 865 1413"
            }, 
            "facility": {
                "address": {
                    "city": "Leipzig", 
                    "country": "Germany", 
                    "zip": "04103"
                }, 
                "name": "Herzzentrum Leipzig GmbH"
            }, 
            "investigator": {
                "last_name": "Gerhard Hindricks, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "2", 
        "overall_contact": {
            "email": "hindg@medizin.uni-leipzig.de", 
            "last_name": "Gerhard Hindricks, MD", 
            "phone": "+49 (341) 865 1413"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Percent of patients with the left ventricle (LV) lead implanted at the site of latest mechanical activation", 
            "safety_issue": "No", 
            "time_frame": "This outcome measure will be assessed after an off-line analysis immediately after implant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01917266"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Response to Cardiac Resynchronization Therapy (CRT) as defined by percent change in end-systolic volume (ESV) at 6-month follow-up relative to baseline.", 
            "safety_issue": "No", 
            "time_frame": "6 months after implant"
        }, 
        "source": "St. Jude Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Jude Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}